From: Leukocyte telomere length in paediatric critical illness: effect of early parenteral nutrition
 | A | B | C | |||
---|---|---|---|---|---|---|
Variable | Estimate (95% CI) for change in telomere length expressed as T/S units, adjusted for risk factors | P value | Estimate (95% CI) for change in telomere length expressed as T/S units, adjusted for risk factors, including duration of PICU stay | P value | Estimate (95% CI) for change in telomere length expressed as T/S units, adjusted for risk factors, including cumulative dose of insulin and acquisition of new infection during PICU stay | P value |
Randomisation to early vs. late initiation of PN | −0.021 (−0.038; –0.004) | 0.01 | −0.020 (−0.037;–0.003) | 0.01 | −0.018 (−0.035; –0.0001) | 0.04 |
Change in fraction of neutrophils from admission to the last day (per % added)a | −0.106 (−0.165; –0.048) | 0.0004 | − 0.115 (−0.174; –0.056) | 0.002 | −0.103 (−0.162; –0.044) | 0.0006 |
Age (per year added) | −0.073 (−0.112; –0.034) | 0.0003 | −0.075 (−0.114; –0.037) | 0.0002 | −0.075 (−0.114; –0.036) | 0.0002 |
Male vs. female sex | −0.017 (−0.034; 0.000) | 0.05 | −0.016 (−0.033; 0.001) | 0.06 | −0.016 (−0.033; 0.000) | 0.05 |
Leukocyte telomere length upon admission (per T/S unit added) | −0.290 (− 0.356; –0.224) | < 0.0001 | −0.290 (−0.356; –0.225) | < 0.0001 | −0.288 (− 0.353; –0.222) | < 0.0001 |
Diagnostic category (as compared with all other categories) | ||||||
 Surgical | ||||||
  Abdominal | 0.138 (0.022; 0.253) | 0.01 | 0.135 (0.019; 0.250) | 0.02 | 0.135 (0.019; 0.250) | 0.02 |
  Cardiac | −0.012 (−0.059; 0.036) | 0.63 | −0.016 (−0.065; 0.032) | 0.50 | −0.009 (−0.057; 0.039) | 0.71 |
  Neurosurgery-traumatic brain injury | −0.025 (−0.092; 0.042) | 0.45 | −0.021 (−0.088; 0.046) | 0.54 | −0.023 (−0.090; 0.045) | 0.51 |
  Thoracic | 0.008 (−0.073; 0.088) | 0.85 | 0.007 (−0.073; 0.087) | 0.86 | 0.004 (−0.077; 0.084) | 0.93 |
  Transplantation | −0.051 (−0.211; 0.109) | 0.53 | −0.060 (−0.220; 0.100) | 0.45 | −0.055 (−0.215; 0.105) | 0.49 |
  Orthopaedic surgery-trauma | 0.022 (−0.062; 0.106) | 0.60 | 0.026 (−0.058; 0.109) | 0.54 | 0.029 (−0.055; 0.113) | 0.50 |
  Other | 0.091 (−0.019; 0.202) | 0.10 | 0.090 (−0.020; 0.201) | 0.10 | 0.094 (−0.016; 0.205) | 0.09 |
 Medical |  |  |  |  |  |  |
  Cardiac | −0.048 (−0.185; 0.089) | 0.49 | −0.050 (−0.187; 0.087) | 0.47 | −0.040 (−0.178; 0.097) | 0.56 |
  Gastrointestinal-hepatic | −0.091 (−0.294; 0.112) | 0.37 | −0.098 (−0.300; 0.104) | 0.34 | −0.088 (−0.291; 0.114) | 0.39 |
  Neurologic | −0.012 (−0.091; 0.067) | 0.76 | −0.016 (−0.095; 0.063) | 0.69 | −0.017 (−0.096; 0.063) | 0.67 |
  Respiratory | −0.014 (−0.113; 0.085) | 0.78 | −0.011 (−0.110; 0.088) | 0.82 | −0.024 (−0.123; 0.076) | 0.64 |
  Other | −0.006 (−0.116; 0.105) | 0.91 | 0.015 (−0.097; 0.127) | 0.79 | −0.006 (−0.116; 0.105) | 0.92 |
PeLOD score first 24 h (per point added)b | −0.020 (−0.069; 0.028) | 0.40 | −0.015 (−0.064; 0.034) | 0.54 | −0.019 (−0.068; 0.030) | 0.44 |
PIM2 score (per point added)c,d | 0.031 (−0.048; 0.111) | 0.44 | 0.048 (−0.033; 0.128) | 0.24 | 0.038 (−0.043; 0.120) | 0.35 |
High vs. medium STRONGkids risk levele | −0.015 (−0.052; 0.022) | 0.42 | 0.013 (−0.024; 0.050) | 0.49 | 0.013 (−0.024; 0.051) | 0.47 |
Infection vs. no infection upon-admission | −0.009 (−0.033; 0.015) | 0.46 | −0.004 (−0.029; 0.021) | 0.74 | −0.004 (−0.029; 0.021) | 0.76 |
Centre (Leuven vs. Rotterdam) | 0.084 (−0.030; 0.198) | 0.14 | 0.090 (−0.024; 0.204) | 0.12 | 0.087 (−0.027; 0.201) | 0.13 |
Height (per percentile of population norms added)f | 0.006 (−0.029; 0.041) | 0.72 | 0.005 (−0.030; 0.039) | 0.79 | 0.005 (−0.029; 0.040) | 0.76 |
Weight (per percentile of population norms added)f | 0.005 (−0.032; 0.042) | 0.79 | 0.006 (−0.031; 0.043) | 0.75 | 0.007 (−0.030; 0.044) | 0.72 |
Chronicity vs. no chronicityg | 0.020 (−0.009; 0.050) | 0.17 | 0.025 (−0.054; 0.005) | 0.09 | 0.021 (−0.008; 0.051) | 0.15 |
Duration of stay in the PICU (per day added) |  |  | −0.144 (−0.284; –0.004) | 0.04 |  |  |
Cumulative dose of insulin (per IU/kg added) |  |  |  |  | −0.091 (−0.198; 0.017) | 0.09 |
New infection vs. no new infection |  |  |  |  | 0.024 (−0.012; 0.059) | 0.19 |